(Q47925916)

English

Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials

scientific article published in October 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/27686028

0 references

Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/27686028

1 reference

based on heuristic

inferred from title

bipolar depression

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Nicola Veronese

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27686028%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27686028%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Leonardo Zaninotto

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27686028%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Christoph Correll

10

object named as

Christoph U Correll

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27686028%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Marc L M van der Loos

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27686028%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Keming Gao

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27686028%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Ayal Schaffer

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27686028%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Catherine Reis

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27686028%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Claus Normann

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27686028%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Ion-George Anghelescu

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27686028%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

publication date

1 October 2016

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/27686028

C N S Spectrums

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27686028%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27686028%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27686028%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

403-418

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27686028%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Lamotrigine in psychiatric disorders

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Differences between unipolar depression and bipolar II depression in women.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Bipolar depression: prototypically melancholic in its clinical features

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Distinguishing between unipolar depression and bipolar depression: current and future clinical and neuroimaging perspectives

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Risk factors for treatment resistance in unipolar depression: a systematic review.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Bipolar depression: overview and commentary

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Pharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxis

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Effect of quetiapine XR on depressive symptoms and sleep quality compared with lithium in patients with bipolar depression

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

The risk of switch to mania in patients with bipolar disorder during treatment with an antidepressant alone and in combination with a mood stabilizer

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Antidepressant-associated mania: soon after switch from fluoxetine to mirtazapine in an elderly woman with mixed depressive features

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Drug interactions involving the new second- and third-generation antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Antiepileptic drugs and adverse skin reactions: An update.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Important clinical features of atypical antipsychotics in acute bipolar depression that inform routine clinical care: a review of pivotal studies with number needed to treat

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

A clinical monitoring form for mood disorders.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Lamotrigine as add-on treatment to lithium and divalproex: lessons learned from a double-blind, placebo-controlled trial in rapid-cycling bipolar disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Efficacy and safety of antidepressant augmentation with lamotrigine in patients with treatment-resistant depression: a randomized, placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Lithium versus lamotrigine augmentation in treatment resistant unipolar depression: a randomized, open-label study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

A randomized, double-blind, placebo-controlled, trial of lamotrigine therapy in bipolar disorder, depressed or mixed phase and cocaine dependence

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Serum levels of substance P and response to antidepressant pharmacotherapy

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Operating characteristics of a rank correlation test for publication bias

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Development of a Rating Scale for Primary Depressive Illness

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Treatment options for bipolar depression: a systematic review of randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Treatments for acute bipolar depression: meta-analyses of placebo-controlled, monotherapy trials of anticonvulsants, lithium and antipsychotics

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Balancing benefits and harms of treatments for acute bipolar depression

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Antidepressant-emergent mood switch in Korean adolescents with mood disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Risk of manic switch associated with antidepressant therapy in pediatric bipolar depression

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Is anticonvulsant treatment of mania a class effect? Data from randomized clinical trials.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Lamotrigine (Lamictal IR) for the treatment of bipolar disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

The 'disconnect' between initial judgments of lamotrigine vs. its real-world effectiveness in managing bipolar disorder. A tale with wider ramifications

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Effectiveness of aripiprazole, olanzapine, quetiapine, and risperidone augmentation treatment for major depressive disorder: a nationwide population-based study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Maintenance therapies in bipolar disorders

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Costs of the principal mood disorders: a study of comparative direct and indirect costs incurred by those with bipolar I, bipolar II and unipolar disorders

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

The prevalence and burden of bipolar depression

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

The societal cost of bipolar disorder in Sweden

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

The long-term natural history of the weekly symptomatic status of bipolar I disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Weight gain and antipsychotics: a drug safety review

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Efficacy and Safety of Lamotrigine as Add-On Treatment to Lithium in Bipolar Depression

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

21 January 2018

Treatment implications of predominant polarity and the polarity index: a comprehensive review

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, double-blind pilot trial comparing lamotrigine versus citalopram for the treatment of bipolar depression

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

7 January 2021

based on heuristic

inferred from DOI database lookup

A Double-Blind, Randomized, Placebo-Controlled Trial of Augmentation With Lamotrigine or Placebo in Patients Concomitantly Treated With Fluoxetine for Resistant Major Depressive Episodes

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

7 January 2021

based on heuristic

inferred from DOI database lookup

Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of depressive symptoms compared with manic symptoms in bipolar disorder: results of a U.S. community-based sample

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacologic approaches to treatment resistant depression: Evidences and personal experience

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

7 January 2021

based on heuristic

inferred from DOI database lookup

Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

7 January 2021

based on heuristic

inferred from DOI database lookup

A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

7 January 2021

based on heuristic

inferred from DOI database lookup

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000523

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47925916&oldid=2175951634"